Insights into the inhibitory mechanism of skullcapflavone II against α-synuclein aggregation and its mediated cytotoxicity-Reference-Cited by-同舟云学术

Insights into the inhibitory mechanism of skullcapflavone II against α-synuclein aggregation and its mediated cytotoxicity

Published:2022-06 Issue: Volume:209 Page:426-440
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Parsafar Soha,Aliakbari Farhang,Seyedfatemi Sepideh Sadat,Najarzadeh Zahra,Hourfar Hamdam,Bardania Hassan,Farhadpour Mohsen,Mohammadi Mehdi,Morshedi Dina

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference69 articles.

1. Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities;Visanji;Transl. Neurodegener.,2019

2. Initiation and propagation of α-synuclein aggregation in the nervous system;Hijaz;Mol. Neurodegener.,2020

3. Parkinson disease epidemiology, pathology, genetics, and pathophysiology;Simon;Clin. Geriatr. Med.,2020

4. Reverse engineering Lewy bodies: how far have we come and how far can we go?;Fares;Nat. Rev. Neurosci.,2021

5. A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson's disease: emerging concepts and challenges;Vasquez;Prog. Neurobiol.,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mechanistic interaction, aggregation and neurotoxicity of α-synuclein after interaction with glycyrrhizic acid: Modulation of synucleinopathies;International Journal of Biological Macromolecules;2024-05

2. The impact of hUC MSC–derived exosome-nanoliposome hybrids on α-synuclein fibrillation and neurotoxicity;Science Advances;2024-04-05

3. Brazilin-7-acetate, a novel potential drug of Parkinson's disease, hinders the formation of α-synuclein fibril, mitigates cytotoxicity, and decreases oxidative stress;European Journal of Medicinal Chemistry;2024-01

4. Recent advances in natural products targeting α-synuclein aggregation or clearance in Parkinson's disease;European Journal of Medicinal Chemistry Reports;2023-12

5. Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson’s Disease Treatment;Mini-Reviews in Medicinal Chemistry;2023-11